...
首页> 外文期刊>Journal of immunotherapy >alpha1-Adrenergic Receptor Antagonists Induce Production of IL-18 and Expression of ICAM-1 and CD40 in Human Monocytes.
【24h】

alpha1-Adrenergic Receptor Antagonists Induce Production of IL-18 and Expression of ICAM-1 and CD40 in Human Monocytes.

机译:alpha1-肾上腺素能受体拮抗剂诱导人单核细胞中IL-18的产生以及ICAM-1和CD40的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

The activation of T cells plays a role in antitumor response. Monocytes activate T cells by inducing the cell-to-cell interaction that involves the engagement of adhesion molecules with their ligands, and the production of IL-18. The authors examined the effect of the quinazoline-based alpha1-adrenergic receptor antagonists bunazosin, doxazosin, prazosin, and terazosin on the expression of adhesion molecules such as ICAM-1, B7.1, B7.2, CD40, and CD40L on monocytes isolated from human peripheral blood mononuclear cells. Doxazosin, prazosin, and terazosin induced the expression of ICAM-1 and CD40 but had no effect on the expression of B7.1, B7.2, and CD40L. Moreover, IL-18 was detected in the medium of incubated monocytes treated with doxazosin, prazosin, and terazosin. Bunazosin did not affect adhesion molecule expression and IL-18 production, suggesting that the chemical structure of quinazoline might not be related to the effect of doxazosin, prazosin, and terazosin. Although caspase-1 inhibitor completely abolished the production of IL-18, anti-IL-18 mAb and caspase-1 inhibitor partially inhibited the increase in ICAM-1 and CD40 expression induced by doxazosin, prazosin, and terazosin. Doxazosin, prazosin, and terazosin can induce monocyte activation with a specific pattern of expression of adhesion molecules and IL-18 production, and this may lead to T-cell activation through the cell-to-cell interaction. The activation of T cells induced by the increase of the expression of ICAM-1 and CD40 and the production of IL-18 may be involved in the anti-cancer effects of doxazosin, prazosin, and terazosin.
机译:T细胞的激活在抗肿瘤反应中起作用。单核细胞通过诱导细胞间相互作用来激活T细胞,这种相互作用涉及粘附分子与其配体的结合以及IL-18的产生。作者研究了基于喹唑啉的α1-肾上腺素受体拮抗剂布纳唑嗪,多沙唑嗪,吡唑嗪和特拉唑嗪对粘附分子如ICAM-1,B7.1,B7.2,CD40和CD40L在单核细胞上表达的影响来自人外周血单核细胞。多沙唑嗪,哌唑嗪和特拉唑嗪诱导ICAM-1和CD40的表达,但对B7.1,B7.2和CD40L的表达没有影响。此外,在用多沙唑嗪,哌唑嗪和特拉唑嗪处理的温育单核细胞培养基中检测到IL-18。布纳唑嗪不影响粘附分子的表达和IL-18的产生,这表明喹唑啉的化学结构可能与多沙唑嗪,哌唑嗪和特拉唑嗪的作用无关。尽管caspase-1抑制剂完全消除了IL-18的产生,但抗IL-18 mAb和caspase-1抑制剂部分抑制了由多沙唑嗪,哌唑嗪和特拉唑嗪诱导的ICAM-1和CD40表达的增加。多沙唑嗪,哌唑嗪和特拉唑嗪可以诱导单核细胞活化,并具有粘附分子表达和IL-18产生的特定模式,并可能通过细胞间相互作用导致T细胞活化。由ICAM-1和CD40的表达增加引起的T细胞活化以及IL-18的产生可能与多沙唑嗪,哌唑嗪和特拉唑嗪的抗癌作用有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号